Follisave

Development-stage medical device company offering a novel, effective, patient-friendly and cost-effective treatment for hair loss (alopecia) caused by chemotherapy in breast cancer and other cancers.

Medical Device
Active
Tel-Aviv, Israel Founded 2021
Website ↗
Last updated 2026-08-18
Total raised
$3.5M
Stage
—
Founded
2021
Headcount
—
HQ
Tel-Aviv, Israel
Sector
Medical Device

About

Follisave is a development-stage medical device company focused on providing a novel, effective, patient-friendly, and cost-effective treatment for hair loss (alopecia) caused by chemotherapy in breast cancer and other cancers. The company's technology is Israeli, and it is currently in clinical trials.

Funding history · 1 round · $3.5M total

2021-11
Seed $3.5M
★ Guangzhou Sino-Israel Biotech Investment Fund (GIBF)

Sectors & technology

Primary sector
Medical Device
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)